Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway InhibitionMater H. Mahnashi, Mahrous A. Abou-Salim|Pharmaceuticals|2022Cited by 14